Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial

Bär, S; Kavaliauskaite, R; Otsuka, T; Ueki, Y; Häner, JD; Siontis, GCM; Stortecky, S; Shibutani, H; Temperli, F; Kaiser, C; Iglesias, JF; van Geuns, RJ; Daemen, J; Spirk, D; Engstrom, T; Lang, I; Windecker, S; Koskinas, KC; Losdat, S; Räber, L

Räber, L (通讯作者),Univ Bern, Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.

EUROINTERVENTION, 2023; 19 (4): E286

Abstract

Background: Treatment with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on top of statins leads to plaque regression and stabilisa......

Full Text Link